IL4 and stroke disorder: In one study, administrating a single dose of Gal-3 recombinant protein into the lateral ventricle 24 h after stroke resulted in increased immune reactivity of Ym1 and up-regulated expression of anti-inflammatory factor IL-4, while reducing the immune reactivity of iNOS and the expression of pro-inflammatory factors (Rahimian et al., 2019).